# Mark Roschewski, M.D. – FDA Inspection, Apr 15, 2024

Source: https://www.keypedia.com/records/fda_inspections/mark-roschewski-md/0aa772c0-4b0b-43a0-9375-6c2220b68c90
Source feed: FDA_Inspections

> FDA inspection 1235997 of Mark Roschewski, M.D., April 15, 2024. Classification: No Action Indicated (NAI). 1 citation under 21 CFR part 312. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1235997
- Company Name: Mark Roschewski, M.D.
- Inspection Date: 2024-04-15
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- [FDA Inspection 1141689 - 2021-05-11](https://www.keypedia.com/records/fda_inspections/mark-roschewski-md/fb9d888a-6b1f-4233-b997-04a383e7defc)

## Related Officers

- [Investigator](https://www.keypedia.com/people/david-l-chon/227b9c21-14c4-442b-bdc3-ad167567fd92)
- [Issuing Officer](https://www.keypedia.com/people/lee-hong-pai-scherf/e6cb2433-ec2b-463f-8beb-5f2bc90a9291)

Company: https://www.keypedia.com/companies/mark-roschewski-md/ea0723cb-f67f-4b83-a845-0e1c0b6e9f92

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c